Phase 1 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with rheumatoid arthritis according to a recognised set of medical classification standards (the 2010 ACR-EULAR criteria — confirm with trial site if unsure whether this applies)
- People who agree not to take traditional medicines or any medications that have not been prescribed by a doctor
- People who have adequate function of the blood, liver, heart, and lungs as determined by testing
Who may not be able to join:
- People who have severe liver disease classified as Child-Pugh class B or C (a medical grading system for liver health — confirm with trial site)
- People who have an autoimmune disease that requires a relatively high daily dose of prednisone or a similar steroid medication (specifically more than 0.5 mg per kilogram of body weight per day)
- People who are not willing to take part in an extended safety monitoring period after the main part of the trial ends
- People who have had a serious infection — such as a severe blood infection, pneumonia, fungal, viral, or other significant infection — within the four weeks before the first dose of the study treatment, if the trial doctors believe this could affect their safety during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 021-61673760
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The Incidence of Subjects with Dose Limiting Toxicities within each dose level cohort
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.